Roivant Sciences Ltd (ROIV)
Debt-to-assets ratio
Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 204,371 | 194,560 | 188,911 | 187,140 | 180,700 | 183,510 | 188,680 | 200,700 | 210,025 | 204,042 | 199,869 | 186,350 |
Total assets | US$ in thousands | 7,222,480 | 7,312,680 | 2,065,540 | 2,136,650 | 2,389,600 | 2,202,960 | 2,215,530 | 2,600,400 | 2,585,130 | 2,799,380 | 3,102,910 | 2,454,700 |
Debt-to-assets ratio | 0.03 | 0.03 | 0.09 | 0.09 | 0.08 | 0.08 | 0.09 | 0.08 | 0.08 | 0.07 | 0.06 | 0.08 |
March 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $204,371K ÷ $7,222,480K
= 0.03
The debt-to-assets ratio of Roivant Sciences Ltd has been relatively stable and low over the past few quarters, ranging from 0.03 to 0.09. This indicates that the company has a low level of debt compared to its total assets, suggesting a conservative approach to financing its operations.
The slight fluctuation in the ratio may be attributed to changes in the company's debt levels or asset composition during the respective periods. Overall, a low debt-to-assets ratio is generally viewed positively by investors and lenders as it signifies lower financial risk and a stronger ability to meet financial obligations. Roivant Sciences Ltd's consistent low debt-to-assets ratio points to prudent financial management and a solid balance sheet position.
Peer comparison
Mar 31, 2024